Nu-Med Plus, Inc. (NUMD)
OTCMKTS · Delayed Price · Currency is USD
0.0200
0.00 (0.00%)
At close: Jan 23, 2026
Nu-Med Plus Market Cap
Nu-Med Plus has a market cap or net worth of $1.67 million as of January 23, 2026. Its market cap has decreased by -33.33% in one year.
Market Cap
1.67M
Enterprise Value
1.87M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.02
Market Cap Chart
Since September 25, 2014, Nu-Med Plus's market cap has decreased from 24.57M to 1.67M, a decrease of -93.20%. That is a compound annual growth rate of -21.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 1.67M | 15.73% |
| Dec 29, 2025 | 1.44M | 12.58% |
| Dec 31, 2024 | 1.28M | -62.05% |
| Dec 28, 2023 | 3.38M | 151.78% |
| Dec 30, 2022 | 1.34M | -51.67% |
| Dec 31, 2021 | 2.78M | -93.86% |
| Dec 29, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Odyssey Health | 6.69M |
| Co-Diagnostics | 6.07M |
| Vycor Medical | 3.67M |
| Fuse Medical | 3.40M |
| Lifeline Biotechnologies | 3.04M |
| AI Maverick Intel | 1.53M |
| St. Joseph | 1.27M |
| Escalon Medical | 1.16M |